Your browser doesn't support javascript.
loading
Development of a peptide-based delivery platform for targeting malignant brain tumors.
Rahn, Jennifer J; Lun, Xueqing; Jorch, Selina K; Hao, Xiaoguang; Venugopal, Chitra; Vora, Parvez; Ahn, Bo Young; Babes, Liane; Alshehri, Mana M; Cairncross, J Gregory; Singh, Sheila K; Kubes, Paul; Senger, Donna L; Robbins, Stephen M.
Afiliação
  • Rahn JJ; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, T2N 4N1, Canada; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, Alberta, T2N 4N1, Canada; Departments of Oncology, University of Calgary, Calgary, Alberta, T2N 4N1, Canada.
  • Lun X; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, T2N 4N1, Canada; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, Alberta, T2N 4N1, Canada; Departments of Oncology, University of Calgary, Calgary, Alberta, T2N 4N1, Canada.
  • Jorch SK; Calvin, Phoebe & Joan Snyder Institute ForChronic Diseases, University of Calgary, Calgary, Alberta, T2N 4N1, Canada; Physiology and Pharmacology, University of Calgary, Calgary, Alberta, T2N 4N1, Canada.
  • Hao X; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, T2N 4N1, Canada; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, Alberta, T2N 4N1, Canada; Departments of Oncology, University of Calgary, Calgary, Alberta, T2N 4N1, Canada.
  • Venugopal C; Department of Surgery, McMaster Children's Hospital, And McMaster Stem Cell and Cancer Research Institute, McMaster University, Hamilton, ON, L8S 4K1, Canada.
  • Vora P; Department of Surgery, McMaster Children's Hospital, And McMaster Stem Cell and Cancer Research Institute, McMaster University, Hamilton, ON, L8S 4K1, Canada.
  • Ahn BY; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, T2N 4N1, Canada; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, Alberta, T2N 4N1, Canada; Departments of Oncology, University of Calgary, Calgary, Alberta, T2N 4N1, Canada.
  • Babes L; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, T2N 4N1, Canada; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, Alberta, T2N 4N1, Canada; Departments of Oncology, University of Calgary, Calgary, Alberta, T2N 4N1, Canada.
  • Alshehri MM; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, T2N 4N1, Canada; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, Alberta, T2N 4N1, Canada; Departments of Oncology, University of Calgary, Calgary, Alberta, T2N 4N1, Canada.
  • Cairncross JG; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, T2N 4N1, Canada; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, Alberta, T2N 4N1, Canada; Clinical Neurosciences, University of Calgary, Calgary, Alberta, T2N 4N1, Canada.
  • Singh SK; Department of Surgery, McMaster Children's Hospital, And McMaster Stem Cell and Cancer Research Institute, McMaster University, Hamilton, ON, L8S 4K1, Canada.
  • Kubes P; Calvin, Phoebe & Joan Snyder Institute ForChronic Diseases, University of Calgary, Calgary, Alberta, T2N 4N1, Canada; Physiology and Pharmacology, University of Calgary, Calgary, Alberta, T2N 4N1, Canada.
  • Senger DL; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, T2N 4N1, Canada; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, Alberta, T2N 4N1, Canada; Departments of Oncology, University of Calgary, Calgary, Alberta, T2N 4N1, Canada. Electronic address: senger@uc
  • Robbins SM; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, T2N 4N1, Canada; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, Alberta, T2N 4N1, Canada; Departments of Oncology, University of Calgary, Calgary, Alberta, T2N 4N1, Canada. Electronic address: srobbins@
Biomaterials ; 252: 120105, 2020 09.
Article em En | MEDLINE | ID: mdl-32417652

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Vírus Oncolíticos Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Vírus Oncolíticos Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá